What products are affected by the Lotte gum recall?

Lotte is recalling about 30,000 units across three gum products sold in Japan, including the “Mecha Fukuramu Bubble Gum Pouch,” per local reports. The company is reviewing related lots and distribution. Customers should refer to official notices for exact product names, lot numbers, and return instructions as the process advances.

Why are methyl paraben and PEG esters an issue in Japan food safety?

Methyl paraben and a PEG ester class cited here are not approved as food additives in Japan. That regulatory status triggers a voluntary pull even without reported health cases. The concern is compliance and documentation, not an observed incident. Authorities prioritize approved additive lists, labeling, and verifiable sourcing.

Are there any health risks reported from the Lotte gum recall?

No health cases have been reported. The recall is precautionary because the additives involved are not approved domestically for food use. Risk depends on dose and exposure, which regulators and company tests evaluate. The core driver is compliance with Japan food safety rules and clear communication to consumers and retailers.

How could the recall affect Lotte’s business near term?

Expect temporary sales softness in gum, added logistics and testing costs, and tighter supplier audits. Shelf checks and paused promotions may dampen visibility until restocking. The scale appears limited, so the main risk is brand trust. Clear updates and quick corrective actions can help contain financial impact in Japan.

Global Market Insights

Lotte Today, January 27: Japan Recalls 30,000 Gum Units on Additives

ByDanny Kontos January 27, 2026

The Lotte gum recall is in focus today after the company began pulling about 30,000 units across three gum products in Japan. The move follows the discovery of unapproved additives, including methyl paraben and a PEG ester class, in an ingredient. No health issues have been reported. For Japan food safety watchers and investors, this product recall Japan story centers on regulatory risk, brand trust, and near‑term sales. We break down the facts and what to track next.